Related Experiment Videos
Plasma concentrations of complement-modulating proteins (C1 inhibitor, C4 binding protein, factor H and factor I) in
K Ohkohchi1, W Torinuki, H Tagami
1Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan.
Insights
This study found elevated levels of complement-modulating proteins, including C4-binding protein (C4bp), factor H, and factor I, in psoriasis patients. These increases correlated with disease severity, suggesting complement system involvement in psoriasis.
Area of Science:
- Immunology
- Dermatology
- Biochemistry
Background:
- The complement system plays a crucial role in immune responses and inflammation.
- Dysregulation of the complement system has been implicated in various inflammatory conditions.
- Psoriasis and related pustular dermatoses are inflammatory skin diseases with incompletely understood pathogenesis.
Purpose of the Study:
- To investigate the plasma levels of complement-modulating proteins in patients with psoriasis and other inflammatory skin diseases.
- To determine if these protein levels correlate with disease activity and extent in psoriatic patients.
- To explore the role of the complement system in the pathophysiology of psoriasis.
Main Methods:
- Single radial immunodiffusion was employed to quantify plasma levels of C1 inhibitor (C1INH), C4-binding protein (C4bp), factor H, and factor I.
- Plasma samples were analyzed from 42 psoriatic patients, 60 patients with other inflammatory skin diseases, and 27 healthy controls.
Main Results:
- Significantly increased levels of C4bp, factor H, and factor I were observed in psoriatic patients and those with related pustular dermatoses.
- These elevated protein levels demonstrated a strong correlation with the extent of skin lesions and overall disease activity in psoriasis.
- In contrast, non-psoriatic inflammatory dermatoses showed only isolated increases in factor H (toxic erythema) and factor I (atopic dermatitis).
Conclusions:
- The findings provide further evidence supporting the involvement of the complement system in the pathogenesis of psoriasis and related sterile pustular dermatoses.
- Elevated levels of specific complement-modulating proteins are associated with disease severity in psoriasis.
- The complement system may represent a potential therapeutic target for psoriasis and related conditions.
Abstract:
By using single radial immunodiffusion, plasma levels of four complement-modulating proteins, i.e. C1 inhibitor (C1INH), C4-binding protein (C4bp), factor H and factor I were measured in 42 psoriatic patients and in 60 patients with other inflammatory skin diseases in comparison with 27 normal controls. In psoriatic patients and those with related pustular dermatoses, the levels of C4bp, factor H and factor I were significantly increased. They correlated well with both extent of skin changes and disease activity. In contrast, in nonpsoriatic inflammatory dermatoses only factor H values were significantly increased in toxic erythema and factor I in atopic dermatitis. These results offer additional support for the hypothesis that the complement system is involved in psoriasis and related sterile pustular dermatoses.